Moody Aldrich Partners LLC Clovis Oncology, Inc. Transaction History

Moody Aldrich Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 31, 2018	SELL	$29.37 - $49.48 $657,065 - $1.11 Million	-22,372 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $185,274 - $274,872	-4,405 Reduced 16.45%	22,372 $1.02 Million
Q1 2018 Apr 26, 2018	BUY	$50.12 - $67.72 $294,254 - $397,584	5,871 Added 28.08%	26,777 $1.41 Million
Q4 2017 Jan 31, 2018	BUY	$57.69 - $84.58 $231,106 - $338,827	4,006 Added 23.7%	20,906 $1.42 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $1.14 Million - $1.43 Million	16,900	16,900 $1.39 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.